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Reduced Mucin-7 (Muc7) Sialylation and
Altered Saliva Rheology in Sjo¨gren’s Syndrome
Associated Oral Dryness*
Nayab M. A. Chaudhury‡, Gordon B. Proctor‡, Niclas G. Karlsson§¶,
Guy H. Carpenter‡, and Sarah A. Flowers§
Sjo¨gren’s syndrome is a chronic autoimmune disorder
characterized by lymphocytic infiltration and hypofunc-
tion of salivary and lacrimal glands. This loss of salivary
function leads to oral dryness, impaired swallowing and
speech, and increased infection and is associated with
other autoimmune diseases and an increased risk of cer-
tain cancers. Despite the implications of this prevalent
disease, diagnosis currently takes years, partly due to the
diversity in patient presentation. Saliva is a complicated
biological fluid with major constituents, including heavily
glycosylated mucins MUC5B and MUC7, important for its
viscoelastic and hydrating and lubricating properties. This
study investigated Sjo¨gren’s patient’s perception of dry-
ness (bother index questionnaires) along with the rheo-
logical, protein composition, and glycan analysis of whole
mouth saliva and the saliva on the mucosal surface (re-
sidual mucosal saliva) to understand the properties that
most affect patient wellbeing. Sjo¨gren’s patients exhib-
ited a statistically significant reduction in residual muco-
sal saliva, salivary flow rate, and extensional rheology,
spinnbarkeit (stringiness). Although the concentration of
mucins MUC5B and MUC7 were similar between patients
and controls, a comparison of protein Western blotting
and glycan staining identified a reduction in mucin glyco-
sylation in Sjo¨gren’s, particularly on MUC7. LC-MS/MS
analysis of O-glycans released from MUC7 by -elimina-
tion revealed that although patients had an increase in
core 1 sulfation, the even larger reduction in sialylation
resulted in a global decline of charged glycans. This was
primarily due to the loss of the extended core 2 disialy-
lated structure, with and without fucosylation. A decrease
in the extended, fucosylated core 2 disialylated structure on
MUC7, residual mucosal wetness, and whole mouth saliva
flow rate appeared to have a negative and cumulative effect
on the perception of oral dryness. The observed changes in
MUC7 glycosylation could be a potential diagnostic tool for
saliva quality and taken into consideration for future thera-
pies for this multifactorial syndrome. Molecular & Cellular
Proteomics 15: 10.1074/mcp.M115.052993, 1048–1059,
2016.
Sjo¨gren’s syndrome (SS) is a chronic autoimmune disorder
with a global prevalence of between 0.5–2.0%, of which 90%
are female (1). The disease is characterized by an infiltration of
lymphocytes into exocrine tissue, including the salivary and
lacrimal glands, leading to glandular hypofunction and symp-
toms of dry mouth (xerostomia) and eyes (1). Chronic dry
mouth leads to an increased risk of malnutrition (2), owing to
problems with mastication, swallowing, and taste (3, 4), as
well as an increase in caries (5) and yeast infection (6). These
symptoms have a profound effect on psychological and social
functioning, resulting in an overall negative effect on quality of
life (7). Sjo¨gren’s can also occur in conjunction with another
autoimmune disease (secondary SS) such as rheumatoid ar-
thritis and systemic lupus erythematosus (8), and patients
have a dramatically increased risk of non-Hodgkins lym-
phoma (relative risk of 13.7) as well as thyroid cancer (relative
risk 2.58) (9). This makes diagnosis essential not only for
effective disease management but also for the monitoring of
other dangerous associated diseases. The heterogeneous
presentation of SS, along with patients seeing different doc-
tors for oral and eye complaints, makes diagnosis difficult and
often delayed for several years. Although diagnostic criteria
have changed over time with the improving knowledge of SS
and now include a range of possible diagnostic benchmarks
(10), a diagnostic tool that effectively describes the quality of
saliva is lacking. As oral dryness is an early and prevalent
symptom in SS (11), diagnosis of this symptom would im-
prove the overall diagnosis of SS.
Saliva is a complicated and dynamic non-Newtonian bio-
logical fluid containing water, ions, and several protein
groups, including mucins, proline rich proteins, amylase, and
immunoglobulins (12). It is produced by the parotid, subman-
dibular, and sublingual bilaterally paired major salivary glands
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as well as the minor salivary glands that are distributed
throughout the oral cavity and number in the hundreds (12).
To facilitate its boundary (surface) and hydrodynamic (fluid)
lubricating roles, saliva comprises whole mouth saliva, which
can be stimulated or unstimulated, and residual mucosal sa-
liva (RMS), the saliva that is retained on oral surfaces (13). A
mucin-rich basal level of saliva, unstimulated whole mouth
saliva (UWMS), is produced at all times with the mucins
principally secreted from the submandibular, sublingual, and
minor glands. Saliva production can be stimulated by chewing
and taste where contribution by the parotid glands, secreting
a mucin-free amylase-rich serous fluid, is greatest followed by
the submandibular glands (12). The RMS is made up of nor-
mal salivary proteins with an increased concentration of se-
creted mucins (14, 15).
Mucins are large, very heavily O-glycosylated proteins. Two
secreted mucins, MUC5B (1 MDa) and MUC7 (150 kDa),
are found in saliva and contain central mucin domains, rich in
serine and threonine residues that covalently bind the O-gly-
cosylation, creating an extended linear structure (16). The two
salivary mucins hold a different range of O-glycans. Both
mucins contain glycans from core 1 and core 2 O-glycans
with a high degree of sialylation; however, those observed on
MUC7 are shorter relative to MUC5B, which are larger, more
complex, and show a greater range (17, 18). Furthermore,
MUC5B glycosylation shows greater individual variation due
to its presentation of glycans reflecting blood group and se-
cretor status (19). The mucins and their glycosylation are
essential to a variety of saliva properties. Their innate role in
microbial defense is to act as decoys of microbial binding
glycans to hinder pathogens from reaching and binding the
mucosal surface (20, 21). They are also important for biolu-
brication, including boundary lubrication, as their negatively
charged glycans give them hydrating and electrostatically
repulsive properties (16, 22).
Mucins also contribute to salivary viscoelasticity (23, 24).
Early investigations demonstrated attenuation of rheological
properties upon removal of mucins and restoration following
reconstitution with the mucin fraction (25). Again, it is the
glycan component that is important for this property as saliva
viscoelasticity is reduced upon degradation of mucin glycans
(26). The diverse importance of mucins and their glycosylation
shows it is imperative to understand any compositional
changes that may occur in SS and lead to negative alterations
in the physical properties of saliva.
Many techniques can be used to assess the physical prop-
erties of saliva and investigate oral dryness-associated dis-
eases, including SS. Assessment of UWMS flow rate is simple
and noninvasive and has been linked to oral dryness below
the hyposalivation threshold rate of 0.1 ml/min (27, 28). This
link is not always apparent with hyposalivation-independent
xerostomia in 20–30% of early stage SS patients (11, 29).
Rheological analysis is another approach to understanding
saliva. Spinnbarkeit is one such property and measures the
ability of a fluid to be drawn into strings, indirectly allowing
measurement of elastic and adhesive properties (30) with the
additional advantage of correlating with viscosity (31). RMS
wetness is another important characteristic, given its involve-
ment in lubrication, that can be measured clinically by the use
of specific filter strips for collection (32). Studies have shown
an inverse correlation between RMS wetness at specific sites
of the mouth, including the palate (32), the anterior tongue
(33), and labial mucosa (27) and hyposalivation. Although
these physical parameters are important indicators of oral
health, they are not effective indicators for all SS patients.
Given the complex nature and the diversity of symptoms
observed in SS, it is essential to have a better understanding
of salivary changes not only in UWMS but also RMS proper-
ties in this disease. To this end, a range of saliva investiga-
tions were undertaken in this discovery project, as well as the
subjective analysis of the patients’ discomfort (Bother Index
questionnaires) to ascertain which properties most affect pa-
tient well-being. These properties included UWMS flow rate,
RMS volume, the rheological property spinnbarkeit, and mu-
cin protein and glycan content. Changes in MUC7 O-glyco-
sylation were also investigated, not only from the UWMS but
also from the low abundance (3 l saliva) RMS from the
lower labial surface.
EXPERIMENTAL PROCEDURES
Ethics Approval—Ethical approval was granted by the National
Research Ethics Service (NRES9 Committee London-Brent (11/LO/
1121). Informed written consent was obtained from all patients, con-
trols, and volunteer subjects included in the study.
Saliva Sample Collection—Saliva samples were collected from pa-
tients diagnosed with Sjo¨gren’s syndrome (n  25) and healthy age-
matched control subjects (n  35). Patients were attending the oral
medical clinic at Guy’s hospital, London. Diagnosis of patients was
achieved using the revised European classification criteria, American-
European Consensus Group (34). UWMS was collected using the
passive drool technique over a 10 min period following a minimum 1 h
fasting period, and flow rates were calculated gravimetrically. Bacte-
rial, cellular, and other debris were removed from UWMS by centri-
fugation (2000  g, 10 min, 4 °C) and the supernatant stored at
80 °C. Mucosal hydration was assessed by collecting residual mu-
cosal saliva from the: anterior hard palate (AHP)1, buccal (BUC),
anterior tongue (AT), and lower labial (LL) oral surfaces using Sialo-
PaperTM collection strips (surface area 44.15 mm2, Oralflow, NY,
USA). Saliva volume was calculated by measuring electrical capaci-
tance of the wet collection strip using a Periotron® 8000 (Oralflow),
the values then converted to fluid volume using a standard curve as
described previously (14). RMS samples were stored at 80 °C and
eluted prior to analysis.
Clinical Oral Dryness Assessment—All subjects were assessed for
xerostomia, the subjective feeling of dryness, using a questionnaire-
1 The abbreviations used are: AHP, anterior hard palate; AT, ante-
rior tongue; BI, Bother Index; BUC, buccal; CODS, Clinical Oral
Dryness Score; CO, control; LL, lower labial; MAL II, Maackia amu-
rensis leukoagglutinin II; PAS, periodic acid-Schiff; PGC, porous
graphitized carbon; RMS, residual mucosal saliva; SNA, Sambucus
nigra agglutinin; SS, Sjo¨gren’s syndrome; TBS-T, TBS-Tween® 20,
UWMS, unstimulated whole mouth saliva.
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type Bother Index (BI) (35) and for objective signs of dryness using the
Clinical Oral Dryness Score (CODS) (36). The CODS comprises 10
clinical features such as sticky mucosa and fissured tongue that are
associated with oral dryness. The BI is a two-part questionnaire, the
first consisting of five questions, B5, and the second a single visual
analogue scale, B1, giving details on a subject’s perception of dry
mouth (xerostomia). In both assessments, a higher score is indicative
of greater levels of oral dryness.
Spinnbarkeit (Rheological) Measurement—A Neva-MeterTM (IMI-
0501, Ishikawa Ironworks Co., Japan) was used to carry out spinn-
barkeit measurement on neat, fresh UWMS at room temperature.
Sample (50 l) was loaded, and three repeat readings were taken.
Saliva was stretched with a constant stretching rate of 5 mm/sec until
break point, which was determined by electrical conductivity (31).
Sample Preparation, Electrophoresis, and Visualization—All sam-
ples were prepared under reducing conditions with 50 mM DTT, 25%
NuPAGE lithium dodecyl sulfate sample buffer (Life Technologies,
Calsbad, USA), and water (RMS samples only) and heat denatured (3
min, 100 °C). For RMS samples lithium dodecyl sulfate, DTT, and
water were applied directly to the SialoPaperTM, heat denatured, and
eluate collected by centrifugation (15,000 g, 2 min). Protein content
was assessed using SDS-PAGE on NuPAGE 4–12% bis-Tris gels
(Life Technologies). For salivary mucin (MUC5B and MUC7) analysis,
gels were stained for glycosylated mucin detection or transferred to
nitrocellulose membranes (for mucin protein immunodetection and
lectin detection) or PVDF membrane (for O-glycan analysis).
Periodic Acid Schiff’s (PAS) staining—PAS oligosaccharide stain
was used to detect the carbohydrate component of the salivary
mucins. Electrophoresed gels were fixed (25% methanol and 10%
glacial acetic acid) for 1 h, followed by a 20 min water wash and
oxidation for 15 min in 2% periodic acid. Gels were then washed in
water for 5 min and placed in Schiff’s reagent (VWR, Lutterworth, UK)
for 30–60 min, in the dark. All steps were carried out under gentle
agitation. Gels were destained in water.
Mucin Western Blotting—Detection of MUC5B and MUC7 was
carried out using antibodies directed to mucin protein core (37). Saliva
was separated by SDS-PAGE and transferred to nitrocellulose mem-
branes for Western blot analysis. Membranes were blocked in 0.1 M
TBS-T (TBS- 0.1% Tween®-20) (for MUC5B) or 2% (w/v) skimmed
milk powder (LabM Ltd., Lancashire, UK) TBS-T solution (for MUC7)
for 60 min. Membranes were incubated for 60 min in monoclonal
antibodies (hybridoma supernatant): EU-MUC5Bb 1:100 or EU-
MUC7a 1:100 (EU Consortium on mucins in inflammatory disease,
gifts of Prof. Dallas Swallow, University College London, UK) or anti-
MUC7 HPA006411 at 0.13 g/ml (Sigma Aldrich, Dorset, UK) in
TBS-T or 2% skim milk in TBS-T. Membranes were then incubated
with polyclonal secondary antibody, goat anti-mouse immunoglobu-
lins HRP conjugated at 0.5 g/ml (P0447, Dako) or goat anti-rabbit
immunoglobulins HRP conjugated at 0.125 g/ml (P0448, Dako) in
TBS-T for 60 min. Membranes were washed 3  5 min with TBS-T
between incubations. ClarityTM Western ECL Substrate (Bio-Rad,
Hemel Hempstead, UK) was used for signal detection with the aid of
a ChemiDocTM MP imaging system (Bio-Rad).
Sialic Acid Detection—Detection of specific sialic acid moieties
was carried out using lectins. Saliva was separated by SDS-PAGE
and transferred to nitrocellulose for lectin detection. Membranes were
processed as for mucin protein detection with the following changes.
Membranes were washed in TBS-T for 30 min. Sialic acid residues
were detected using Sambucus nigra agglutinin (SNA) lectin, which
preferentially binds -2, 6 linked sialic acid, and Maackia amurensis
leukoagglutinin II (MAL II) lectin, which preferentially binds -2, 3
linked sialic acid (Vector Laboratories, CA, USA), diluted to 0.05 g/ml
and 0.4 g/ml, respectively, in TBS-T, and incubated for 60 min.
Lectin signal was detected using Vectastain® ABC Kit (Vector Lab-
oratories) and the chemiluminescent substrate described above. Lec-
tin staining was validated by digesting saliva with a -2,3 linked
sialic-acid-specific sialidase (New England Biolabs, P0720S) and a
general -2,3, -2,6, -2,8 linked sialic-acid-specific sialidase (New
England Biolabs, P0728S) before lectin staining.
Mucin Quantification—Densitometry using purified mucin stand-
ards (gifts of Prof. Claes Wickstro¨m, Malmo¨ University, Sweden) of
known concentrations were used to generate a standard curve to
calculate mucin protein concentrations in saliva samples. In the case
of sialic acids where a purified standard was not used, pixel intensi-
ties were used directly. Densitometry measurement for Western blot-
ted MUC5B, MUC7, and sialic acid was achieved using ChemiDocTM
complementary software ImageLabTM (Version 4.0 build 16, Bio-Rad).
Densitometry measurement for PAS-stained MUC5B and MUC7 was
achieved using ImageJ software (38).
Preparation of O-glycans by Reductive -Elimination—Saliva sam-
ples separated by SDS-PAGE and transferred to PVDF membranes
were stained for 20–30 min with Alcian blue stain solution (0.125%
Alcian blue, 25% ethanol, 10% acetic acid) and destained in methanol
overnight. Alcian blue stained MUC7 band (running between 188 and
98 kDa) was excised. Release of O-glycans from excised MUC7
bands was achieved by reductive -elimination (39). Briefly, samples
were incubated for 16 h at 50 °C with 20 l of fresh reductive -elim-
ination solution (50 mM sodium hydroxide and 0.5 M sodium borohy-
dride). Samples were neutralized with 1 l glacial acetic acid.
Desalting of neutralized O-glycan samples was achieved using 40
l of AG50WX8 resin (BioRad, Hercules, CA) in C18 ZipTips (Millipore,
Billerica, USA), recovering glycans with water as an unretarded frac-
tion (39). Glycan eluate was completely dried by vacuum evaporation
and further desalted with 5 50 l 1% glacial acetic acid in methanol.
Samples were stored at 20 °C and rehydrated in water immediately
prior to LC-MS/MS analysis. A pooled sample of saliva was included
in each gel to monitor transfer and -elimination efficiency.
LC-MS/MS of O-Glycans from MUC7—An HTC PAL autosampler
(CTC Analytics) and an Agilent 1100 series HPLC were used, attached
to a LTQ linear ion trap (Thermo Fisher Scientific) for negative ion
mode LC-MS/MS. Fused silica HPLC columns with an inner diameter
of 250 m and 10 cm length were packed with 5 m porous graph-
itized carbon (PGC) particles. A 10–15 l flow rate after passive
splitting (from 250 l/ml) was used for O-glycan separation. The
mobile phase used consisted of solvent A (10 mM ammonium bicar-
bonate) and solvent B (10 mM ammonium bicarbonate with 80%
acetonitrile). Initially, 100% of solvent A was run for 5 min duration.
This was changed to solvent B to 45% in 41 min followed by 100%
solvent B for 8 min and equilibrated to 100% solvent A for 25 min. A
standard of glycans released from porcine gastric mucin was run
every four samples to monitor instrument performance. Three glycans
were specifically monitored and CVs maintained below 10 for con-
sistency. Sample order was randomized, and blanks were run after
every sample.
XcaliburTM (Rev.2.0.7, Thermo Fisher Scientific) software was used
to visualize data for peak identification and quantification of relative
glycan abundance. All glycans were detected as reduced alditols.
O-glycans were identified by manual annotation of MS/MS spectra
using fragmentation principals as previously described (40) and fol-
lowing guidelines set out by previous, extensive analysis of MUC7
O-glycans released under the same conditions (18). Low-intensity
isomers not confirmed in multiple samples were not included in the
study. Peaks were considered if they were 5% of the glycan base
peak. It was assumed that all reducing ends were GalNAc-ol. All
MS/MS were inspected manually to assess spectra quality and frag-
mentation patterns were also compared with those present in the
publically available UniCarb-DB glycan MS/MS and retention time
database containing 635 spectra of 451 different structures (41)
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(www.unicarb-db.org). Structures used in the results and supplemen-
tary tables accurately depict the level of annotation, and for instance,
where the location of a residue is unknown, it is shown with a bracket.
All raw data used for MS analysis in this study were submitted via
Proteios (42) for public availability in SweStore, the Swedish data
storage infrastructure (links in Supp. 2).
Relative, quantitation was performed as described previously (43).
Intensities were determined from integrated single-ion chromato-
grams that were normalized to total O-glycan ion intensity. All data
were converted to relative percentage to allow for comparison be-
tween samples with differing intensities. Relative refers to the relative
intensity of each glycan or glycan group within a patient sample.
Quantitation was completed with no adjustment to the original data.
No sodium adducts were apparent during quantitation analysis. Iso-
mers were effectively separated by PGC chromatography. Quantita-
tion was performed on individual isomers, and only after this analysis
were isomers grouped to streamline the data where isomers differ-
ences were not statistically significant. As patient samples were avail-
able in very minute amounts, replicates were not possible. To improve
statistical confidence, all patient groups started with 12–14 patients
with patients removed when intensity was too low for effective anno-
tation and quantitation. Data are shown in the supplementary tables
with the standard error shown.
Statistical Analysis—All data were tested for normality (D’Adostino
and Pearson omnibus normality test) to establish the type of analysis
(parametric or nonparametric) required. Differences between samples
were analyzed using unpaired, two tailed t test and two-way analysis
of variance for parametric data. The Mann–Whitney test was applied
for nonparametric data. All data analyses were carried out using
GraphPad Prism 6 software (La Jolla, California, USA).
RESULTS
Saliva Flow Analysis, Rheology, Residual Mucosal Saliva
and Oral Dryness Scores—Comparative analysis of salivary
physiological properties was carried out between age-
matched SS patients and controls as shown in Table I. Pa-
tients were assessed using both objective (CODS) and sub-
jective (BI) dryness assessments indicating all SS patients
used in the study suffered from oral dryness (p  .001). SS
patients UWMS flow rate (0.15  0.03 ml/min, n  25) was
statistically significantly (p  .0001) reduced compared with
controls (0.41  0.05 ml/min, n  35). RMS was measured
using filter paper strips on four mucosal surfaces (AHP, BUC,
AT, and LL), revealing a characteristic intraoral wetness pat-
tern, with the AHP the least hydrated followed by the LL, BUC,
and AT. This pattern was consistent in both patients and
controls, suggesting it is independent of UWMS flow rate.
RMS was significantly reduced on all four mucosal surfaces of
the SS patients (Table I). PAS staining was also performed on
RMS samples and showed a trend toward an increased level
of PAS staining in SS patients compared with controls (Table
I), suggesting that the reduction in RMS volume in SS patients
is due to a decrease in water but not mucin.
Extensional rheology, or spinnbarkeit, is the stringiness of a
substance and is an indirect measure of the adhesive prop-
erties of a solution (30). Patient spinnbarkeit was statistically
significantly lower (p  .05), forming much shorter filaments
than the controls. Alteration in this viscoelastic property of
saliva, in addition to reduced salivary flow rate and mucosal
hydration, indicate the quality of saliva was affected in addi-
tion to its quantity. Thus, further investigation of saliva com-
position was undertaken.
UWMS Mucin Composition—Salivary MUC5B and MUC7
are important contributors to saliva viscoelasticity, thus anal-
ysis of these proteins was performed. The detection of
MUC5B and MUC7 protein and glycan components was car-
ried out using antibodies directed to nonglycosylated regions
of the protein core (37) and PAS stain (Fig. 1A). Mean MUC5B
and MUC7 protein concentrations were similar in patients and
controls, as were the PAS glycan staining results, with no
statistically significant difference between patients and con-
trols (Fig. 1C). An estimate of the level of mucin glycosylation
TABLE I
Comparison of UWMS flow rate, rheology and dryness assessment for SS patients and healthy controls
Sjögren’s patients Controls
Mean  S.E. n Mean  S.E. n
Age (years) 55.00  3.16 25 55.71  3.01 35
CODS (score) 4.04  0.42a 24 0.27  0.08 30
BI (score) B5 7.46  1.01a 24 0.13  0.06 32
B1 5.98  0.63a 0.03  0.03
UWMS Flow Rate (ml/min) 0.15  0.03a 25 0.41  0.04 35
RMS (l) AHP 0.36  0.05b 24 1.09  0.16 35
BUC 2.08  0.21c 3.05  0.16
AT 2.27  0.26c 3.28  0.13
LL 1.20  0.18c 2.18  0.22 34
RMS MUC7 PAS (staining intensity) AHP 1504  886b 23 292  40 30
BUC 488  137 23 271  43 30
AT 721  154 23 266  34 30
LL 877  200 14 669  171 29
Spinnbarkeit (mm) 4.67  0.78d 21 28.54  5.66 30
Objective dryness assessment was achieved using the Clinical Oral Dryness Score (CODS). Bother Index (BI), a two-part questionnaire (B1
and B5), was used for subjective dryness assessment. Unstimulated whole mouth saliva (UWMS) flow rate was calculated gravimetrically.
Residual mucosal saliva (RMS) was collected and measured from four oral mucosal surfaces: anterior hard palate (AHP), buccal (BUC), anterior
tongue (AT), and lower labial (LL) and stained by PAS. Extensional rheological was quantified by measuring saliva spinnbarkeit. Statistical
significance is shown as a p  .0001, b p  .05, c p  .001, d p  .01.
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per unit protein was calculated for each sample and the mean
results shown in Fig. 1C. The proportion of MUC7 glycan/
protein was significantly reduced (p  .0001) in SS (2.42 
0.56) compared with controls (15.88  5.47). A similar trend
(p  .053) was observed in MUC5B with patients showing
lower glycosylation (1.79  0.28) than controls (7.77  2.29).
Sialic acid content of UWMS MUC5B and MUC7 was as-
sessed using SNA lectin, which preferentially binds -2,6
linked sialic acid residues, and MAL II lectin, which preferen-
tially binds -2,3 linked sialic acid. MUC5B preferentially
bound SNA, and this lectin was used for MUC5B sialic acid
content determination (Fig. 1B). MAL II was used for MUC7 as
this lectin bound favorably (Fig. 1B). Total UWMS mucin sialic
acid content (sum of MUC7 MAL II and MUC5B SNA) was
significantly reduced (p  .041) in patients (97.29  16.12)
compared with controls (147.6  19.80, Fig. 1C). This reduc-
tion in sialylation, in conjunction with a reduction in the pro-
portion of mucin glycan/protein, indicates altered mucin gly-
cosylation in SS.
MUC7 O-Glycan LC-MS/MS analysis of Sjo¨gren’s Patients
and Controls—Given the difference observed in mucin sialy-
lation between SS patients and controls, further investigation
of MUC7 O-glycosylation was undertaken. UWMS and RMS
from the lower labial surface were analyzed as pathology in
lower labial gland biopsies has been well described in SS (44).
The analysis of O-glycans from RMS has not previously been
undertaken given the small amount of saliva sampled as an
RMS collection strip is only able to hold a maximum volume of
3 l of total saliva. The amount of saliva sampled here
ranged from 1.2  0.2 in SS samples to 2.2  0.2 in controls.
The most intense glycans were analyzed by LC-MS/MS anal-
ysis using PGC chromatography to separate isomers. Relative
quantitation O-glycans for each sample was then carried out
(Supp. 1). The highly sensitive nature of this method allowed
the analysis of all 13 SS RMS.LL samples; however, only four
of the control samples provided quantifiable data, reducing
the usefulness of this data particularly given the high variation
present between the four samples. This lack of intensity in the
control RMS.LL suggests that, although the SS samples had
a reduced volume of RMS (Table I), MUC7 was more concen-
trated compare with controls. PAS staining in SS RMS sam-
ples (877 200 staining pixel intensity) also tended toward an
increased level compared with controls (669  171 staining
pixel intensity, Table I) particularly when the reduced volume
in SS samples (SS 1.2  0.2, CO 2.2  0.2) is considered.
The types of O-glycan structures identified did not vary
between UWMS and RMS samples or between control and
SS samples and are glycans previously reported on salivary
MUC7(18). Considerable variation in individual glycan abun-
dance was observed between individuals (Supp. 1), irrespec-
tive of their health status in both UWMS and RMS.LL. The
identified glycans were made up of core 1 (Gal 1–3 GalNAc-
ol,m/z 384.1) and core 2 (GlcNAc 1–6 (Gal 1–3) GalNAc-ol,
m/z 587.2) structures as shown in the UWMS SS and control
base peak chromatograms in Fig. 2. The core 1 structures
included the sulfated (m/z 464.1), sialylated (branched and
linear structures, m/z 675.2), and disialylated structures (m/z
966.3). Many MUC7 samples also carried the small blood
group H trisaccharide Fuc 1–2 Gal 1–3 GalNAc-ol (m/z
530.2). The core 2 structures included the neutral structure
with the addition of a galactose (Gal 1–4 GlcNAc 1–6 (Gal
1–3) GalNAc-ol, m/z 749.3) from which all other core 2
structures extended, including the further addition of a fucose
to the GlcNAc residue (m/z 895.3). The remaining core 2
structures were the sialylated (two isomers, m/z 1040.4), di-
sialylated (m/z 1331.5) and the largest fucosylated disialylated
structure core 2 structure (m/z 1477.5).
The comparison of UWMS and RMS.LL O-glycan LC-
MS/MS data showed some trends consistent between the
patient and control groups (Fig. 3). RMS.LL samples had a
greater proportion of total sialylated structures compared with
UWMS (p  .05) in both patients (RMS.LL 79.1  3.7, UWMS
56.8  8.3) and controls (RMS.LL 90.5  1.4, UWMS 81.0 
3.1), an increase predominantly due to core 2 disialylated
structures (Table II). Sulfation, however, showed a trend to-
ward reduction in RMS.LL compared with UWMS in both
patients (RMS.LL 6.9  3.0, UWMS 12.1  3.4) and controls
(RMS.LL 2.2  0.3, UWMS 3.3  0.6). Overall, RMS.LL had a
greater abundance of longer, sialylated sugar structures and
reduced sulfation compared with UWMS.
Comparison of the SS patient and control MUC7 O-glycan
abundance data is shown for individual glycans in Fig. 3 and
SNA MLA II
SS UWMS CO UWMS
PAS PAS
MUC5B
MUC7
WB WB
MUC5B
MUC7
A C
B
  Sjögren's Patients Controls 
Mean ± SE n Mean ± SE n 
Mucin Protein              
(WB, μg/ml) 
MUC5B 364.57 ± 62.58 25 376.63 ± 68.54 35 
MUC7 75.54 ± 14.17 25 74.17 ± 10.69 35 
Glycosylated Mucin     
(PAS, μg/ml) 
MUC5B 640.51 ± 86.82 22 562.08 ± 44.55 35 
MUC7 256.03 ± 85.90 22 296.52 ± 45.64 35 
Mean of Individual 
Mucin Glycan/ Protein 
Proportions  
MUC5B 1.79 ± 0.28 22 7.77 ± 2.29 30 
MUC7 2.42 ± 0.56  22 15.88 ± 5.47 30 
Total Sialic Acid (pixel intensity)   97.29 ± 16.12  8 147.6 ± 19.80 11 
188 188
188
FIG. 1. Comparison of UWMS MUC5b and MUC7 from SS patients and controls. (A) Mucins were detected using PAS stain for mucin
glycosylation detection (PAS) and protein detected using Western blotting (WB) with antibodies directed to a nonglycosylated region of the
protein. (B) Sialic acid was assessed by SNA (MUC5B) and MALII (MUC7) lectins. (C) Quantification of mucins used serially diluted purified
mucin standards and the mucin glycan/protein proportion calculated individually and the mean calculated. Statistical significance is shown as
* p  .05, **** p  .0001.
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glycan groups in Table II with all individual patient data shown
in Supp. 1. Patient UWMS had a higher abundance of core 1
structures (41.6  6.2) compared with controls (27.7  2.8),
which had higher core 2 abundance. The sulfated core 1 (m/z
464.1, S(Gal 1–3 GalNAc)) was greater in patients (12.1 
3.4, p  .05) than in controls (3.3  0.6). The abundance of
sialylated core 2 structures was statistically significantly lower
in patients (SS 41.4  8.8, CO 64.5  3.9, p  .05) with this
reduction primarily due to a reduction in disialylated struc-
tures (SS 26.7 6.6, CO 45.3 3.8, p .05). As shown in Fig.
3, the most obvious and statistically significant reduction (p 
.04) in core 2 disialylated structures is the largest glycan
included in the study, the fucosylated, disialylated extended
core 2 structure (m/z 1477.5), where SS patients’ UWMS
MUC7 contained almost half (11.2  3.2) of that observed in
controls (21.4  3.3). Together, these results indicate a sta-
tistically significant reduction in extended core 2 disialylated
structures in patients UWMS compared with controls.
Comparative analysis of patient and control RMS.LL sam-
ples was less informative given the number of control samples
(n  4) was too small and the variation too large to give
sufficient power to any statistical analysis. These data do,
however, show trends that may be used as a guide for further
research (Fig. 3). Similar to the trends observed in UWMS,
patient RMS had a higher abundance of neutral core 1 struc-
tures (9.1  1.2) compared with controls (4.3  1.8). An
overall reduction in core 2 sialylated structures on SS MUC7
(61.0  2.9) was also apparent when compared with controls
(75.2  5.0); however, the alteration in distribution of the
individual glycans (above molecular weight 1000, Fig. 3) in
control RMS.LL is perhaps more to do with the variation in this
subject group. The sulfated core 1 showed a trend toward an
increase in patients’ RMS.LL (Fig. 3). These data suggest that
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FIG. 2. LC(PGC)-MS/MS analysis of UWMS MUC7 O-glycans from SS patients and controls. Control (A) and SS patient (C) saliva
samples separated by SDS-PAGE, transferred to PVDF membrane, and stained with Alcian blue. Base peak chromatograms of the UWMS
MUC7 O-glycans from a control (B) and SS patient (D). O-glycans from MUC7 bands were released using reductive -elimination and analyzed
using LC(PGC)-MS/MS. O-glycan alditols are labeled with observed m/z and appropriate structural definition.  Sialic acid, Œ fucose, F
galactose, f N-acetylgalactosamine (GalNAc), f N-acetylglucosamine (GlcNAc), and S sulfate.
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FIG. 3. Relative percentage abundance of MUC7 O-glycans in
UWMS and RMS. LL of SS patients and controls. Relative percentage
abundance is shown by size of circle with all isomers grouped. UWMS
SS patients (n 12) and controls (n 13) and RMS.LL SS patients (n
12) and controls (n  4) are shown. Neutral glycans are in yellow,
sulfated in black, monosialylated in purple, and disialylated in red.
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like UWMS, RMS.LL samples display changes in the distribu-
tion of MUC7 O-glycans in SS and that these changes may be
similar to those observed in UWMS, including a reduction in
core 2 disialylated structures, a reciprocal increase in neutral
core 1 glycans, and an increase in core 1 sulfation.
Saliva Properties, the Perception of Dryness and Diagnostic
Markers of Saliva Quality—The diagnosis and disease moni-
toring of SS are exacerbated by the lack of markers that
effectively explains the dryness felt by the patient. Thus, the
development of salivary markers of oral dryness in SS patients
could potentially expedite its diagnosis. The sum of the two
Bother Indices (B1 and B5) is a semi-quantitative descriptor of
the subjective perception of dryness felt by the SS patient.
Both UWMS flow rate (Fig. 4A) and LL.RMS (Fig. 4B) show a
general trend that, as these properties are reduced, the pa-
tient feels more uncomfortable, giving a higher Bother Index.
However, not all patients follow this trend. Some have an
unexpectedly low Bother Index sum despite a low UWMS flow
rate (red circle, patients K, M, and J) and LL.RMS wetness
(red circle, patients A, K, J, and B). That is, these patients do
not feel the symptoms of dry mouth as severely as would be
expected. This suggests that it is not only the volume of saliva
that defines the perception of oral dryness in SS.
Spinnbarkeit and content of disialylated core 2 O-glycans
on UWMS MUC7 both showed clear differences between
controls and patients and are plotted in Fig. 4C and produce
interesting patient subgroups. Spinnbarkeit is shown in this
patient population to very effectively separate patients and
controls. The average spinnbarkeit of patients is statistically
significantly reduced (p value  .01) by almost six times
(4.67  0.78 compared with 28.54  5.66).
Core 2 disialylation groups controls into a single group
while the SS patients form three small subgroups, one with a
core 2 disialylation content higher than the controls and two
with a lower content. The higher subgroup (red circle, patients
K, J, and L) has a lower average BI (6.7) than the two low sialic
acid groups (BIs of 13.0 and 18.5) as well as a similar LL.RMS
as the lowest group (1.9 l compared with 1.4 l), suggesting
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FIG. 4. Saliva properties and the perception of dryness. BI is a subjective measure of dry mouth based on a two-part patient questionnaire
with a larger number denoting greater discomfort. BI of SS patients plotted against (A) UWMS flow rate and (B) LL.RMS wetness. An estimation
of the clinically expected trend lines are shown on A and B. The red circles represent the area where patients have a lower BI than would be
expected from their UWMS flow rate and LL.RMS wetness, designated the sialyl-compensated group. (C) The relative percentage of the
disialylated core 2 structure in UWMS plotted against spinnbarkeit of SS patients and controls. BI is the average bother index score of SS
patients in the circle and LL.RMS the average volume (l) of lower labial RMS from patients in the red (sialyl-compensated group), blue
(sialyl/flow reduced group), and green (sialyl/flow deficient group) circles. Letter plot points (A-K) denote specific SS patients and black circles
are controls.
TABLE II
Relative percentage abundance of MUC7 O-glycan groups in UWMS and RMS.LL of SS patients and controls
UWMS RMS.LL
Sjögren’s Controls Sjögren’s Controls
mean  S.E. mean  S.E. mean  S.E. mean  S.E.
n 12 13 13 4
Core 1 41.6  6.2 27.7  2.8 34.0  2.8 21.9  4.4
Core 2 58.4  6.2 72.3  2.8 66.0  2.8 78.1  4.4
Neutral glycans Total 31.1  7.0 15.7  3.0 14.0  1.4a 7.3  1.6
Core 1 14.1  4.2 8.0  1.6 9.1  1.2a 4.3  1.8
Core 2 17.0  3.4a 7.8  2.1 4.9  1.2 3.0  0.9
Sialylated glycans Total 56.8  8.3a 81.0  3.1 79.1  3.7a 90.5  1.4
Core 1 15.4  2.3 16.5  1.5 18.1  2.0 15.3  4.7
Core 2 41.4  8.8a 64.5  3.9 61.0  2.9a 75.2  5.0
mono- 30.2  3.0 35.7  1.1 27.1  1.4 30.0  4.3
di- 26.7  6.6a 45.3  3.8 52.0  3.7 60.5  4.0
Sulfated Core 1 12.1  3.4a 3.3  0.6 6.9  3.0 2.2  0.3
Relative quantification is based on LC-MS/MS data with intensities determined and concerted to relative percentage. Glycans are grouped
according to core (1 or 2) and charge, including neutral structures and negatively charged sialylated and sulfated structures. Monosialylated
structures are (m/z) 675.2, 1040.4, and 1186.4 and disialylated structures are (m/z) 966.3, 1331.5, and 1477.5. Statistical significance is shown
as a where p  .05.
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that the higher content of core 2 disialylation has improved the
patient’s feeling of discomfort from dryness. This group is
designated the sialyl-compensation group. It is interesting to
note that patients K and J were also in the groups of patients
with BI lower than expected for their UWMS flow rate and
LL.RMS wetness. The other two groups, blue, sialyl/flow re-
duced group and green sialyl/flow deficient, both have lower
core 2 disialylation than the controls and differ in BI as well as
LL.RMS. A lower core 2 disialylation content as well as a low
LL.RMS produces a higher Bother Index. It is essential to
note, however, that these subgroups are very small and fur-
ther analysis is needed to confirm and further understand this
interesting observation.
Overall, this shows that SS is multifactorial and that the
three properties of UWMS flow rate, LL.RMS wetness, and
sialic acid content, give additive effects so that, with the loss
of each additional property, the perception of dryness by the
patient is worsened. Also, the sialic acid content of MUC7
appears to compensate for a reduced flow rate or LL.RMS
and may be a potential diagnostic indicator of saliva quali-
ty and, along with other diagnostics such as UWMS flow rate
and RMS volume, may be a useful descriptor of dryness.
DISCUSSION
The complicated nature of dry mouth in SS has led to
difficulty in assigning a biochemical or biophysical property
that is an effective and easy monitor descriptor for the symp-
toms felt by the patient. This is due to a lack of understanding
as to what changes occur in SS and which of these changes
are the cause of disease and which an effect. As oral dryness
is an early and prominent symptom of SS, effective diagnosis
of this aspect would accelerate the clinical assessment of SS.
The study presented here was undertaken to ascertain the
physical and biochemical properties of saliva that correlate
with the subjective perception of dry mouth. Saliva from SS
showed negative changes in quantity and physical properties
as well as a reduction in mucin glycosylation content. An
examination of the glycosylation of MUC7 showed dramatic
differences in SS, particularly a reduction in core 2 disialylated
structures. A comparison of physical and glycosylation
changes and the patients’ perception of dryness was under-
taken in an attempt to better understand this difficult-to-
define property. This analysis suggested that UWMS flow
rate, RMS, and core 2 disialylated O-glycan content may have
a cumulative impact on the feeling of dry mouth. It was also
shown that the rheological properties of saliva are dramati-
cally and consistently lost in SS patients.
All patients expressed discomfort from the feeling of dry
mouth and showed objective signs of oral dryness (CODS) as
well as significantly reduced UWMS flow rate and mucosal
hydration (RMS volume). Changes in salivary gland histology
and diminished salivary gland output are well established
features of SS (45). A significant decrease in UWMS (46, 47)
and minor labial gland (46) flow rates have been reported in
SS; however, no change has been observed in the flow rates
from minor palatal (47) or buccal (46) glands. This suggests
that glands may be affected differently, and as mucosal hy-
dration is reduced in SS, the affected gland secretions may be
important for RMS production. The novel use of spinnbarkeit
showed a reduction in extensional viscosity in SS UWMS. The
spinnbarkeit of SS patients was consistently low, making it
clear that not only the amount of RMS and UWMS but the
functional lubricating properties of saliva are also altered in
SS.
Saliva protein composition changes have been observed in
SS; however, variation among patients did not correlate with
clinical, serological, or histological disease severity (48). The
removal of high molecular weight proteins leads to a near
complete fall in saliva lubrication (49), suggesting the high
molecular weight mucins are important for oral lubrication.
Here, using Western blot quantification, no change in the
amount of MUC5B and MUC7 protein in UWMS was ob-
served in SS patients; similar findings have been shown in
histological sections of minor glands (50). Given that glyco-
sylation accounts for up to 80% of the mass of salivary
mucins (17), it is essential to investigate this component of the
glycoproteins. Deglycosylation results in a reduction in the
viscoelasticity and lubricating properties of mucins (26, 51).
Thus, the proportion of glycans held on the mucin protein
backbone was analyzed, and a statically significant reduction
in O-glycosylation was observed for MUC7, as well as a
decrease in sialic acid residues. Sialic acids were detected
using two lectins: SNA and MALII, which showed binding
preferences that have been reported previously (52) and co-
incides with the observation that nearly all sialic acids are
-2,3 linked on MUC7 (18). The reduction of MUC7 glycosy-
lation in SS indicated their altered structure, and further de-
tailed MUC7 O-glycan analysis was undertaken.
Much of the work on oral lubrication has focused on the
gel-forming mucin MUC5B; however, purified fractions of sal-
ivary mucin (MUC5B) at normal physiological concentrations
do not replicate the gel-forming network of saliva (53). Al-
though MUC5B is important for oral lubrication, it is insuffi-
cient on its own; other salivary components are essential.
Interestingly, it is MUC7 that has a positive correlation with
saliva spinnbarkeit (23), not MUC5B (54), suggesting the for-
mer may be more important for hydrodynamic lubrication than
previously thought. The occurrence of MUC7, along with
MUC5B, in the RMS suggests it may also play a role in
boundary lubrication; therefore, both UWMS and RMS MUC7
were analyzed by LC-MS/MS.
MUC7 O-glycans identified were the core 1 (Gal1–
3GalNAc) and core 2 (GlcNAc1–6(Gal1–3)GalNAc) struc-
tures observed previously (18). MUC7 glycans in UWMS from
SS patients had a significantly lower abundance of sialylated
glycans, which was primarily due to a reduction in core 2
disialylated structures (m/z 1331.5/665.7 and 1477.5/738.8).
The negative charge conferred by sialic acid serves a range of
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roles, including the interaction with water molecules, creating
a hydration shell and improved hydration and lubrication (16).
Thus, the loss of negatively charged glycan residues is a
proposed mechanism for oral dryness through the reduced
water retention capacity of mucins, leading to reduced mu-
cosal hydration (50). The abundance of negative charge also
confers electrostatic repulsion properties suggested to give
the mucins their rigid linear structure (16). Atomic force mi-
croscopy analysis has shown that the deglycosylation of por-
cine gastric mucin results in tightly packed globular aggre-
gates rather than the usual extended fibers (51). Furthermore,
degradation of sialic acid is a proposed mechanism for re-
duced mucin viscoelasticity in saliva (26), as well as the pres-
entation of decreased mucin viscosity and thinner discharge
in women with bacterial vaginosis due to increased sialidase
activity (55). A reduction in sialic acid, as shown here in SS,
has a range of potential effects on the physical rheological
properties of saliva as they relate to hydration and lubrication.
Interestingly, it is extended core 2 and disialylated structures
that are altered, with no change observed in core 1 sialylation,
suggesting it is not only sialic acid content but perhaps the
extended nature of the glycans that is also important.
RMS O-glycan analysis was difficult due to the very low
quantity collected clinically (1–2 l whole saliva). Analysis of
control RMS samples was more difficult, suggesting SS pa-
tients have a higher concentration of MUC7 at the mucosal
surface, also shown by PAS staining. These findings coincide
with previous observations of concentrated mucin on the
mucosal surface of patients with salivary gland hypofunction
and reduced mucosal wetness (14, 15). The filter paper ad-
sorption method for RMS analysis could also collect a minor
amount of sloughed epithelial cells, which show an enrich-
ment of proteins, including mucins (56). The general enrich-
ment in mucins observed at mucosal surfaces in SS could be
the result of altered glycosylation reducing the mucin hydra-
tion shell and creating a general reduction in the water com-
ponent of the RMS. Comparison of UWMS and RMS analysis
is tentative given the limited control samples analyzed; how-
ever, RMS showed a trend toward a greater relative percent-
age of extended core 2 sialylated glycans in both controls and
patients. The lower turnover of RMS increases the exposure
of mucin glycans to bacterial sialidases (57) capable of de-
grading these glycans (58). Interestingly, analysis of total O-
glycans from buccal epithelial cells also showed a greater
relative abundance in sialylated glycans relative to whole sa-
liva (20), indicating a higher abundance of sialic acid residues
at the mucosal interface. The electrostatic repulsion proper-
ties of the central mucin domain have been suggested to
confer essential boundary lubrication properties, not just for
salivary mucins but other similar lubricating glycoproteins
such as lubricin found in the synovial fluid of the joint (16).
Lubricin has positively charged terminal regions flanking the
central negatively charged domain, and these hydrophobic
regions are suggested to be important for the adherence of
lubricin to the cartilage surface (59). A similar mechanism has
been proposed for the boundary lubricating layer of the oral
mucosa (60).
Biophysical salivary properties in SS were investigated to
ascertain if these could be linked to patients’ oral symptoms.
Oral symptoms of SS are early onset, and saliva is easily
sampled, making this an ideal route to improving the current
severe delays in SS diagnosis. Although the sample numbers
used in this study are too low to make further groupings
certain, the incomplete understanding of this disease makes
initial analyses necessary to direct further research. To
this end, physical properties were compared with the Bother
Indices, which describes the severity of the patient’s discom-
fort from dry mouth symptoms. While UWMS flowrate and
RMS volume showed a general correlation with Bother Index,
not all patients followed this trend with some feeling better
and others worse than would be expected from these param-
eters. When the proportion of the extended disialylated core 2
structure was included, this parameter explained the Bother
Index for many of the outlying sialyl-compensated or sialyl/
flow reduced or deficient patients. This suggests that these
factors are cumulative and that the retention of one property
may, to some extent, alleviate the patient’s feeling of dry
mouth, and the loss of one may exacerbate the condition
despite the maintenance of the other properties. The charac-
terization of dry mouth associated with a range of differing
conditions and disease states (61, 62) has proven challenging
due, in part, to its occurrence with (28, 63) and without (4, 63)
reduced salivary gland output. Hyposalivation-independent
xerostomia is reported in 4–50% of oral dryness cases (4, 32,
63). This suggests that the investigation of the MUC7 glycan
changes observed here are worth investigating in a larger
subset of xerostomia patients to ascertain if this descriptor
may be a helpful addition to flow rate analysis as an initial
examination of saliva quality.
Sjo¨gren’s syndrome patients do not have oral symptoms
limited to dry mouth but also have an increased incidence of
recurring candidiasis (6). Salivary glycans have been shown to
have a protective effect against Candida albicans—an orga-
nism able to bind a range of mucin oligosaccharide structures,
acting as binding decoys and removing the organisms in the
saliva before they can attach to the oral surface (20). Patho-
genic Candida glabrata, the second most common cause of
candidiasis, has been shown, by glycan microarray analysis,
to bind to terminal galactose residues (64). The Western blot-
ting and PAS staining analyses in our study suggested a
reduction in glycosylation on salivary mucins, and LC-MS/MS
analysis showed an increase in neutral structures with termi-
nal galactose residues, both of which are likely to increase
candidiasis. These glycan changes may result in a reduction
in Candida clearance and allow increased binding to RMS
MUC7, which, like UWMS, showed an increase in terminal
galactose residues leading to easier attachment to buccal
cells.
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A statistically significant increase in the amount of MUC7
core 1 sulfation was observed. This same core 1 3-linked gal
sulfation has been shown to be increased in another systemic
inflammatory disease, rheumatoid arthritis (65). Although sul-
fate, like sialic acid, carries a negative charge, given the low
abundance of the sulfated core 1 structure compared with the
highly abundant sialic acid, it is unlikely that they play a major
role in lubrication but, instead, may have immunological
and/or binding functions. A recent study has shown that
structures including this motif, human salivary MUC5B, and
the Sulfo-Lewis A antigen (SO3-3Gal1–3GlcNAc) may be
able to induce proinflammatory cytokines interleukin 6 and
tumor necrosis factor alpha through a Toll-like receptor-4
mediated pathway (66). This suggests that changes in glyco-
sylation may be involved in disease processes rather than
simply a response to the inflammatory state, an idea that
warrants further research. A reduction in Sulfo-Lewis A on
MUC5B has been shown in SS by Western blotting (50),
suggesting that glycan changes may differ between the sali-
vary mucins in SS. Overall, it is clear that the salivary MUC7
O-glycosylation changes observed in SS could be responsible
for a range of physical, immunological, and pathological prob-
lems associated with this complex syndrome.
Concluding Remarks—This study was undertaken to ascer-
tain the salivary physical, protein, and glycan compositional
changes that occur in SS as well as the patients’ perception of
their discomfort from dry mouth symptoms. A reduction in
UWMS flow rate, RMS volume, and spinnbarkeit (extensional
rheology) was observed as well as changes in the salivary
mucins MUC5B and, especially, MUC7. The observation of
reduced glycosylation on MUC7 led to the detailed LC-MS/MS
O-glycan analysis of MUC7 from UWMS, as well as RMS to
determine the specific changes during SS. MUC7 from SS, both
UWMS and RMS, showed a reduction in extended core 2
disialylated structures, resulting in an overall decrease in nega-
tively charged sialic acid residues. A lack of negatively charged
glycans is a proposed mechanism for reduced water retention,
leading to less hydrated and lubricating mucins. The use of this
property, along with UWMS flow rate and RMS volume, sug-
gested a cumulative impact of these three parameters on the
symptom of dry mouth. Overall, this suggests that MUC7 O-
glycan changes in SSmay alter the physical properties of saliva,
leading to the symptom of dry mouth.
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